1.
Thewjitcharoen Y, Yenseung N, Butadej S, Nakasatien S, Chotwanvirat P, Chatchomchuan W, et al. Real-World Use of Once-Weekly Semaglutide in Thai Patients with Type 2 Diabetes Mellitus in a Private Hospital Setting. J ASEAN Fed Endocr Soc [Internet]. 2023 Mar. 2 [cited 2024 Nov. 21];38(1):21-8. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/2493